Roivant Sciences Ltd (NASDAQ: ROIV): Today’s Most Interesting Shares

In the last trading session, 4.98 million shares of the Roivant Sciences Ltd (NASDAQ:ROIV) were traded, and its beta was 1.30. Most recently the company’s share price was $10.94, and it changed around $0.34 or 3.21% from the last close, which brings the market valuation of the company to $8.82B. ROIV currently trades at a discount to its 52-week high of $13.24, offering almost -21.02% off that amount. The share price’s 52-week low was $8.06, which indicates that the current value has risen by an impressive 26.33% since then. We note from Roivant Sciences Ltd’s average daily trading volume that its 3-month average coming to 7.39 million.

Roivant Sciences Ltd (NASDAQ:ROIV) trade information

Instantly ROIV has showed a green trend with a performance of 3.21% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -2.58% year-to-date, but still up 2.15% over the last five days. On the other hand, Roivant Sciences Ltd (NASDAQ:ROIV) is 7.78% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $15, which translates to bulls needing to increase their stock price by 27.07% from its current value. Analyst projections state that ROIV is forecast to be at a low of $10 and a high of $18.

Roivant Sciences Ltd (ROIV) estimates and forecasts

Roivant Sciences Ltd share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 13.25 percent over the past six months and at a 31.65% annual growth rate that is well above the industry average of 13.00%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -55.00% in revenue this quarter, and will report a decrease of -21.10% in the next quarter. The year-over-year growth rate is expected to be 137.20%, up from the previous year.

Consensus estimates provided by 8 financial analysts predict the company will bring in an average of $32.81 million in revenue for the current quarter. 7 analysts expect Roivant Sciences Ltd to make $48.84 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $27.38 million and $25.07 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 19.80%. Forecasts for the next quarter put sales growth at 94.80%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 21.79%.